A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.

M Keown, L Poller, S Ibrahim, G Lowe, M Moia, AG Turpie, C Roberts, den Besselaar AM van, der Meer FJ van, A Tripodi, G Palareti, C Shiach, S Bryan, M Samama, M Burgess-Wilson, A Heagerty, P Maccallum, D Wright, J Jespersen, Alexander G TurpieAnton M H P van den Besselaar, Felix J M van der Meer, Anna-Marie Munster (Collaborator), Bodil Leed (Collaborator), Christine Bowyer (Collaborator), Christian Chillou (Collaborator), Mai Defard (Collaborator), Hillel Halkin (Collaborator), Ronen Loebstein (Collaborator), Elizabeth Naparstek (Collaborator), Ilya Kirgner (Collaborator), Polona Peternel (Collaborator), Barbara Krevel (Collaborator), Mojca Stegnar (Collaborator), Daniel Marques-Dias (Collaborator), Walter Ageno (Collaborator), Francesco Dentali (Collaborator), Herbert Watzke (Collaborator), Barbara Weisser (Collaborator), M Angeles Fernandez (Collaborator), Bernard Chatelain (Collaborator), Ivan Cornet (Collaborator), A S Gallus (Collaborator), Jenny Osmond (Collaborator), John Luckit (Collaborator), Frances Charles (Collaborator), Burgess Wilson Michael

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)487-494
    Number of pages7
    JournalThrombosis and Haemostasis
    Volume101
    Issue number3
    DOIs
    Publication statusPublished - Mar 2009

    Keywords

    • Clinical events
    • Computer-dosage
    • Safety DAWN AC
    • Warfarin

    Cite this